Pushkal Garg, EVP Chief R&D at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 3,492 shares at $323.62 ($1.1M) on 2026-03-02, disclosed to the SEC on 2026-03-04.
Seasonal sale ($1.1M) by EVP Chief R&D — this insider has traded ALNY in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $323.62 | 50 | $16K | 1.4% |
| 2 | $324.65 | 97 | $31K | 2.8% |
| 3 | $325.63 | 277 | $90K | 8.0% |
| 4 | $326.81 | 421 | $138K | 12.2% |
| 5 | $327.67 | 353 | $116K | 10.2% |
| 6 | $328.71 | 107 |
| $35K |
| 3.1% |
| 7 | $329.71 | 182 | $60K | 5.3% |
| 8 | $330.85 | 87 | $29K | 2.5% |
| 9 | $331.93 | 101 | $34K | 3.0% |
| 10 | $332.64 | 42 | $14K | 1.2% |
| 11 | $316.74 | 355 | $112K | 9.9% |
| 12 | $319.06 | 317 | $101K | 8.9% |
| 13 | $320.48 | 640 | $205K | 18.1% |
| 14 | $321.50 | 463 | $149K | 13.2% |
| Total | $323.63 avg | 3,492 | $1.1M | 100% |
| Filing → |
| ALNY | SELL | 2026-02-17 | $695K | — | Filing → |
| ALNY | SELL | 2026-01-14 | $548K | — | Filing → |
| ALNY | SELL | 2025-10-03 | $5.3M | — | Filing → |